Dr. Rosenzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
North Campus Research Complex
2800 Plymouth Rd, NCRC Building 25
Ann Arbor, MI 48109Phone+1 734-647-2080
Summary
- Dr. Anthony Rosenzweig is a cardiologist at the University of Michigan Medical Center. He is the inaugural director of the newly established Institute for Heart and Brain Health. He received his medical degree from Harvard Medical School and has been in practice 33 years. He oversees an active research program focused on developing novel therapeutic approaches for heart failure and other cardiovascular diseases.
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1987 - 1989
- Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986
- Harvard Medical SchoolClass of 1984
- Massachusetts General HospitalFellowship, Cardiovascular Disease
Certifications & Licensure
- MI State Medical License 2023 - 2026
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2003
Publications & Presentations
PubMed
- Exercise-Induced Cardiac Lymphatic Remodeling Mitigates Inflammation in the Aging Heart.Kangsan Roh, Haobo Li, Rebecca Nicole Freeman, Luca Zazzeron, Ahlim Lee
Aging Cell. 2025-03-13 - 2 citationsCITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice.Carolin Lerchenmüller, Margaret H Hastings, Charles P Rabolli, Fynn Betge, Mani Roshan
Molecular Therapy. 2024-10-02 - 10 citationsThe traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial.Iokfai Cheang, Wenming Yao, Yanli Zhou, Xu Zhu, Gehui Ni
Nature Medicine. 2024-08-01
Press Mentions
- Kentucky, Michigan Scientific Researchers Awarded $2 Million to Study New Heart Disease, Stroke TreatmentsMay 26th, 2023
- This Next Step of Integrating Mass General Brigham Will Be the Toughest One YetSeptember 27th, 2022
- Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsSeptember 8th, 2022
- Join now to see all
Grant Support
- Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular LevelUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2027
- Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular LevelUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: